Procept BioRobotics: UBS Sees 72% Price Potential and the Prospect of Increasing Utilization in 2026 and 2027
Reading Time: 3 minutes
Robotic Urology and Aquablation Procept BioRobotics Corp. (PRCT) is a company in the field of surgical robotics that specializes in developing and marketing transformative solutions in urology to advance patient care. The core business revolves around the AquaBeam Robotic System. This advanced, image-guided surgical robotic system is used for minimally invasive urological procedures, with the initial and primary focus on treating Benign Prostatic Hyperplasia (BPH), the benign enlargement of the prostate that affects millions of men worldwide...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
